3Kol A,Bourcier T,Lichtman AH, et al. Chlamydial and human heat shock protein bos activate human vascular endothelium, smooth muscle cells,and macrophages.J clin Invest, 1999,103(4) :571 - 577.
4Moazde TC, Kuo CC, Grayston JT, et al . Evidence of systemic dissemination of chlamydia pneumoniaevia macrophages in the mouse .J Infect Dis, 1998,177(5) : 1322 - 1325.
5Dechend R, Maass M, Gieffers J, et al . Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF -kappa B and induces tissue factor and PAI- 1 expression : a potential link to accelerated arteriosclerosis. Circulation, 1999,100 ( 13 ) : 1369 -1373.
6Coombes BK, Mahony JB. cDNA array analysis of altered gene expression in human endothelial cells in response to chlamydia pneumoniae infection, lnfect Immun ,2001,69(3) : 1420 - 1427.
7Anderson JL, Muhlestein JB, carlquist J, et al. Randondzed secendary prevention trial of azithromycin in patients with aronary artery disease and serological evidence for cilamydia pneumonia infection:The Azithromycin in coronary Artery Disease Elimination of myocardial infection with Cilamydia ( ACADEM1C ) study. Circulation, 1999,99 (12) :1540 - 1547.
10Futterman LG,Lemberg L.Fifty percent of patients with coronary artery disease do not have any of the conventional risk faction[J].Am J Crit Care,1998,7:240
